Results 201 to 210 of about 2,522,370 (217)

Zoledronic acid

Reactions Weekly, 2015
openaire   +2 more sources

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

Annals of Oncology, 2009
Evangelos Terpos, Efstathios Kastritis, C Bamia   +2 more
exaly  

New research findings on zoledronic acid: Survival, pain, and anti-tumour effects

Cancer Treatment Reviews, 2008
Fred Saad
exaly  

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases

Annals of Oncology, 2007
Jean-Jacques Body, S Tjulandin
exaly  

Zoledronic acid

Reactions Weekly, 2018
openaire   +1 more source

Zoledronic-acid

Reactions Weekly, 2022
openaire   +1 more source

Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients

Annals of Oncology, 2012
Erich Solomayer, H -J Luck, P Hirnle
exaly  

Denosumab versus zoledronic acid in patients previously treated with zoledronic acid

Osteoporosis International, 2015
Grigorios Sakellariou, Stergios Polyzos, Polyzois Makras   +2 more
exaly  

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)

Annals of Oncology, 2014
Hein Putter
exaly  

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

European Journal of Cancer, 2012
Pablo Maroto Rey, Salvatore Siena, Fred Saad   +2 more
exaly